List of Publications Prof. Dr. Andreas Kirschning

Showing results 81 - 90 out of 324

2016


Dibbert, N., Krause, A., Rios-Camacho, J. C., Gruh, I., Kirschning, A., & Dräger, G. (2016). A Synthetic Toolbox for the In Situ Formation of Functionalized Homo- and Heteropolysaccharide-Based Hydrogel Libraries. Chemistry - A European Journal, 22(52), 18777-18786. https://doi.org/10.1002/chem.201603748
Donner, J., Reck, M., Bergmann, S., Kirschning, A., Müller, R., & Wagner-Döbler, I. (2016). The biofilm inhibitor Carolacton inhibits planktonic growth of virulent pneumococci via a conserved target. Scientific Reports, 6, Article 29677. https://doi.org/10.1038/srep29677
Pfeffer, T. J., Sasse, F., Schmidt, C. F., Lakämper, S., Kirschning, A., & Scholz, T. (2016). The natural diterpene tonantzitlolone A and its synthetic enantiomer inhibit cell proliferation and kinesin-5 function. European Journal of Medicinal Chemistry, 112, 164-170. https://doi.org/10.1016/j.ejmech.2016.02.022
Gille, F., & Kirschning, A. (2016). Studies on the synthesis of peptides containing dehydrovaline and dehydroisoleucine based on copper-mediated enamide formation. Beilstein Journal of Organic Chemistry, 12, 564-570. https://doi.org/10.3762/bjoc.12.55
Hoepfner, J., Kleinsorge, M., Papp, O., Ackermann, M., Alfken, S., Rinas, U., Solodenko, W., Kirschning, A., Sgodda, M., & Cantz, T. (2016). Biphasic modulation of Wnt signaling supports efficient foregut endoderm formation from human pluripotent stem cells. Cell Biology International, 40(5), 534-548. https://doi.org/10.1002/cbin.10590
Hartwig, J., & Kirschning, A. (2016). Flow Synthesis in Hot Water: Synthesis of the Atypical Antipsychotic Iloperidone. Chemistry - A European Journal, 22(9), 3044-3052. https://doi.org/10.1002/chem.201504409
Busch, T., Dräger, G., Kunst, E., Benson, H., Sasse, F., Siems, K., & Kirschning, A. (2016). Synthesis and antiproliferative activity of new tonantzitlolone-derived diterpene derivatives. Organic and Biomolecular Chemistry, 14(38), 9040-9045. https://doi.org/10.1039/c6ob01697a
Müller, R., & Kirschning, A. (2016). Verbundprojekt: TTU 09.903 - Optimisation of the Cystobactamides, a novel class of broad spectrum antibiotics from myxobacteria: Bereich: DZIF TTU 9 “Neuartige Antiinfektiva”: Schlussbericht. Helmholtz-Zentrum für Infektionsforschung. https://doi.org/10.2314/GBV:876762097

2015


Bułyszko, I., Dräger, G., Klenge, A., & Kirschning, A. (2015). Evaluation of the Synthetic Potential of an AHBA Knockout Mutant of the Rifamycin Producer Amycolatopsis mediterranei. Chemistry - A European Journal, 21(52), 19231-19242. https://doi.org/10.1002/chem.201503548
Perin, P. M., Haid, S., Brown, R. J. P., Doerrbecker, J., Schulze, K., Zeilinger, C., von Schaewen, M., Heller, B., Vercauteren, K., Luxenburger, E., Baktash, Y. M., Vondran, F. W. R., Speerstra, S., Awadh, A., Mukhtarov, F., Schang, L. M., Kirschning, A., Müller, R., Guzman, C. A., ... Pietschmann, T. (2015). Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology, 63(1), 49-62. https://doi.org/10.1002/hep.28111